ReviewPhage-tail-like bacteriocins as a biomedical platform to counter anti-microbial resistant pathogens
Under a Creative Commons license
open access
Graphical Abstract
Abbreviations
AHL
N-acyl-homoserine lactone
PTLBs
Phage tail-like bacteriocins
RBPs
receptor binding proteins
MDR
Multi-Drug Resistant
AMR
Antimicrobial Resistance
XDR
Extensively Drug Resistant
LPS
Lipopolysaccharides
Cryo-EM
Cryogenic Electron Microscopy
ssDNA
Single stranded DNA
RBP
Receptor binding protein
CD
Clostridium difficile
CDI
Clostridium difficile infection
PAK
Pseudomonas aeruginosa strain K
PA14
Pseudomonas aeruginosa strain 14
PAO1
Pseudomonas aeruginosa strain 1
DNA
Deoxyribonucleic acid
CDC
Centre for Disease Control and Prevention
STEC
Shiga toxin-producing E. coli
USA
United States of America
WHO
World Health Organization
EHEC
Enterohemorrhagic Escherichia coli
lmaA
Listeria monocytogenes gene B
lmaD
Listeria monocytogenes gene D
Keywords
Bacteriocins
Phage
Multi-drug resistant pathogen
Anti-microbial activity
Phage tail-like bacteriocin
Cited by (0)
- 1
These authors have an equal contribution.
© 2022 The Author(s). Published by Elsevier Masson SAS.